Alzheimer's disease drug development pipeline: 2019
Author:
Affiliation:
1. Department of Brain HealthUniversity of Nevada, Las Vegas (UNLV)School of Integrated Health SciencesLas VegasNVUSA
2. Cleveland Clinic Lou Ruvo Center for Brain HealthLas VegasNVUSA
3. USHendersonNVUSA
Funder
National Institute of General Medical Sciences
Keep Memory Alive
Publisher
Wiley
Subject
Psychiatry and Mental health,Clinical Neurology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.trci.2019.05.008
Reference47 articles.
1. Revising the definition of Alzheimer's disease: a new lexicon
2. Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria. Alzheimer's & dementia;Dubois B.;J Alzheimer's Assoc,2016
3. Report of the task force on designing clinical trials in early (predementia) AD
4. U.S. Food and Drug Administration.Guidance for Industry Alzheimer's Disease: Developing Drugs for the Treatment of Early Stage Disease.2013 Food and Drug Administration Washington D.C.
Cited by 548 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. In-house data adaptation to public data: Multisite MRI harmonization to predict Alzheimer’s disease conversion;Expert Systems with Applications;2024-03
2. Individual and dual trajectories of insomnia symptoms and body mass index before and after retirement and their associations with changes in subjective cognitive functioning;Preventive Medicine;2024-02
3. Polarity directed solvent extracts from Bukiniczia Cabulica (Boiss.) Lincz. ameliorate scopolamine induced amnesia: HPLC-DAD polyphenolics analysis, cholinesterase, COX2, BACE1 inhibitory, anti-amyloid, antioxidant, molecular docking and behavioral correlates;Journal of Molecular Liquids;2024-02
4. Recent trends in treatment strategies for Alzheimer's disease and the challenges: A topical advancement;Ageing Research Reviews;2024-02
5. Survey on the current situation for early diagnosis of dementia and contributing factors in Japan;Psychogeriatrics;2024-01-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3